Legal Representation
Attorney
Michele M. Glessner
USPTO Deadlines
Application History
17 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 30, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 30, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 24, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 4, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 4, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Sep 4, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Sep 4, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Sep 4, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Aug 28, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 28, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 28, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 28, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| May 28, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 28, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 27, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 27, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 6, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 035
Business consulting services for start-up companies in the field of inflammation and neurological diseases caused by inflammation for developing therapeutic platforms
Class 036
Venture capital financing; venture capital advisory services; venture capital funding services, namely, providing financing to emerging and start-up companies
Class 042
Scientific research and development in the field of inflammation and neurological diseases caused by inflammation for developing therapeutic platforms for further development by commercial entities; Consulting services in the field of scientific and medical research and development in the field of inflammation and neurological diseases caused by inflammation for developing therapeutic platforms; consulting services in the field of medical research in the field of inflammation and neurological diseases caused by inflammation for developing therapeutic platforms; Consulting services in the field of technology research in the field of inflammation and neurological diseases caused by inflammation for developing therapeutic platforms
Class 044
Consulting services in the field of medical treatment in the field of inflammation and neurological diseases caused by inflammation for developing therapeutic platforms
Classification
International Classes
035
036
042
044